Sacubitril/valsartan compared to ramipril in high risk post myocardial infarction patients stratified according use of mineralocorticoid receptor antagonists: Insight from PARADISE MI trial
29 August 2022 (15:40 - 15:50)
Organised by:
About the speaker
Herlev-Gentofte University Hospital, Gentofte (Denmark)
5 More presentations in this session
Doctor A. Boehmer (Wiesbaden, DE)
Doctor J. Curtain (Dublin, IE)
Doctor B. Ohnewein (Salzburg, AT)
Doctor V. Cassano (Catanzaro, IT)
Access the full session
The Event
ESC Congress 2022
29 August 2022
15:40 CET
You may be interested in
Congress Presentation
Congress Session
